[Mechanism study of antisense cyclin B1 in tumorigenesis inhibition using proteomic technique]

Tao Yang1, Ling Zhang, Fei Yan

  • 1State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, PR. China. ppyangtao@163.com

Abstract

Insights

Down-regulating cyclin B1 using antisense RNA may inhibit colon cancer by altering proteins involved in cell growth and death. This study identified key protein changes, revealing potential molecular mechanisms for this anti-tumor effect.

Area of Science:

  • Molecular Biology
  • Proteomics
  • Oncology

Context:

  • Cyclin B1 plays a crucial role in cell cycle regulation and tumorigenesis.
  • Previous studies suggest down-regulating cyclin B1 expression can inhibit tumor growth.
  • The precise molecular mechanisms underlying this inhibition require further elucidation.

Purpose:

  • To investigate the molecular mechanisms of antisense cyclin B1 in inhibiting tumorigenesis.
  • To identify differentially expressed proteins in mouse colon carcinoma CT26 cells following transfection with antisense cyclin B1.
  • To elucidate the role of these proteins in cancer development and progression.

Summary:

  • Mouse colon carcinoma CT26 cells were transfected with a plasmid expressing antisense cyclin B1.
  • Comparative proteomic analysis using 2-DE, MALDI-TOF-MS, and Mascot identified seven differentially expressed proteins.
  • Axin2 and DR5 were significantly upregulated, while RFP17, mKIAA1195, and LOC77035 were downregulated, with Axin2 and DR5 expression validated by Western blot.

Impact:

  • Identified several proteins (e.g., Axin2, DR5) involved in cell proliferation, differentiation, migration, apoptosis, and transcriptional control.
  • Suggests that the antitumor effect of antisense cyclin B1 is mediated by the complex interplay of these differentially expressed proteins.
  • Provides a foundation for understanding the molecular basis of antisense cyclin B1 therapy in colon cancer and potentially other malignancies.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...